Insmed Incorporated
INSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,325,529 | $4,352,019 | $2,458,239 | $3,053,904 |
| - Cash | $555,030 | $482,374 | $1,074,036 | $716,782 |
| + Debt | $1,309,944 | $1,203,994 | $1,177,865 | $612,268 |
| Enterprise Value | $12,080,443 | $5,073,639 | $2,562,068 | $2,949,390 |
| Revenue | $363,707 | $305,208 | $245,358 | $188,461 |
| % Growth | 19.2% | 24.4% | 30.2% | – |
| Gross Profit | $277,965 | $239,635 | $190,232 | $144,309 |
| % Margin | 76.4% | 78.5% | 77.5% | 76.6% |
| EBITDA | -$818,794 | -$660,177 | -$447,365 | -$383,647 |
| % Margin | -225.1% | -216.3% | -182.3% | -203.6% |
| Net Income | -$913,772 | -$749,567 | -$481,534 | -$434,654 |
| % Margin | -251.2% | -245.6% | -196.3% | -230.6% |
| EPS Diluted | -5.57 | -5.34 | -3.91 | -3.88 |
| % Growth | -4.3% | -36.6% | -0.8% | – |
| Operating Cash Flow | -$683,882 | -$536,247 | -$400,439 | -$363,302 |
| Capital Expenditures | -$21,923 | -$13,288 | -$9,878 | -$7,289 |
| Free Cash Flow | -$705,805 | -$549,535 | -$410,317 | -$370,591 |